San Francisco, CA, United States of America

Caricia Catalani

This inventor holds 14 USPTO granted patents. Top assignee: Gilead Sciences, Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Caricia Catalani. Retrieved from https://idiyas.com/inventor/caricia-catalani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 92.9

Average Co-Inventor Count = 10.5

ph-index = 4

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Caricia Catalani: Pioneering Innovator in San Francisco

Introduction: Caricia Catalani, a prolific inventor based in San Francisco, CA, has made significant contributions to the field of pharmaceutical packaging. With a total of 12 patents to his name, Catalani continues to push boundaries in innovation.

Latest Patents: Catalani's latest patents include groundbreaking advancements in pharmaceutical packaging technologies, enhancing the safety and efficacy of medicines for patients worldwide.

Career Highlights: Currently employed at Gilead Sciences, Inc., a renowned pharmaceutical company, Catalani's expertise and inventive spirit have been instrumental in the development of novel packaging solutions. His innovative approach has set a new standard in the industry.

Collaborations: Collaborating closely with colleagues such as Joseph Anthony Cordova and Jesse Arnold Fourt, Catalani has fostered a dynamic work environment that encourages creativity and problem-solving. Together, they have achieved remarkable milestones in the realm of pharmaceutical packaging.

Conclusion: Caricia Catalani stands as a shining example of a pioneering inventor, dedicated to driving innovation and making a positive impact in the healthcare sector. His relentless pursuit of excellence continues to inspire others in the field, shaping the future of pharmaceutical packaging.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…